Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke.

Saved in:
Bibliographic Details
Title: Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke.
Authors: Cottarelli A; Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Department of Medicine, Columbia University Irving Medical Center, New York, NY, 10032, USA., Jamoul D; Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, USA., Tuohy MC; Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, USA., Shahriar S; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Wyss Institute for Biologically Inspired Engineering, Boston, MA 02115, USA., Glendinning M; Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, USA., Prochilo G; Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, USA., Edinger AL; Departments of Developmental and Cell Biology and Pharmaceutical Sciences, University of California, Irvine, CA 92697, USA., Arac A; Department of Neurology, David Geffen School of Medicine, University of California in Los Angeles, Los Angeles, CA, 90095, USA., Agalliu D; Department of Neurology, Columbia University Irving Medical Center, New York, NY, 10032, USA.; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 20. Date of Electronic Publication: 2025 May 20.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2023.08.29.555373